当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析 - 现金流量表

海翔药业

(002099)

  

流通市值:101.14亿  总市值:101.33亿
流通股本:16.16亿   总股本:16.19亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金993,992,352.52699,368,481.78344,510,881.751,343,861,950.08
  收到的税费返还100,327,020.6656,936,665.7532,821,522.6797,432,207.02
  收到其他与经营活动有关的现金133,469,750.34107,995,448.1638,505,632.68105,889,847
  经营活动现金流入小计1,227,789,123.52864,300,595.69415,838,037.11,547,184,004.1
  购买商品、接受劳务支付的现金754,301,089.48542,898,159.92266,034,434.68743,428,837.13
  支付给职工以及为职工支付的现金253,652,609.17174,682,411.4594,770,898.09333,163,703.94
  支付的各项税费82,641,878.0262,035,708.1533,110,944.2760,469,711.33
  支付其他与经营活动有关的现金120,235,960.9683,422,200.3746,791,682.95235,286,881.13
  经营活动现金流出小计1,210,831,537.63863,038,479.89440,707,959.991,372,349,133.53
  经营活动产生的现金流量净额16,957,585.891,262,115.8-24,869,922.89174,834,870.57
二、投资活动产生的现金流量:
  收回投资收到的现金130,489.88130,489.88-24,000,000
  取得投资收益收到的现金7,272,551.357,272,551.356,990,103.35-
  处置固定资产、无形资产和其他长期资产收回的现金净额117,441.330,975.8-8,087,222.86
  收到的其他与投资活动有关的现金419,327,624.71404,296,712.03388,216,053.0310,038,151.33
  投资活动现金流入小计426,848,107.24411,730,729.06395,206,156.3842,125,374.19
  购建固定资产、无形资产和其他长期资产支付的现金61,784,910.2845,269,659.3834,545,637.96122,109,749.79
  支付其他与投资活动有关的现金311,375,983.19309,402,602.6612,360,237.43447,409,030.4
  投资活动现金流出小计373,160,893.47354,672,262.0446,905,875.39569,518,780.19
  投资活动产生的现金流量净额53,687,213.7757,058,467.02348,300,280.99-527,393,406
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,000,000
  其中:子公司吸收少数股东投资收到的现金---1,000,000
  取得借款收到的现金1,777,230,0001,304,700,000769,700,0002,506,700,000
  收到其他与筹资活动有关的现金205,440,000156,800,00049,400,000266,499,490
  筹资活动现金流入小计1,982,670,0001,461,500,000819,100,0002,774,199,490
  偿还债务支付的现金1,771,200,000971,500,000479,663,0002,323,697,450
  分配股利、利润或偿付利息支付的现金18,755,203.6913,302,918.046,739,966.3128,062,295.36
  支付其他与筹资活动有关的现金147,305,569.4287,467,585.9648,869,439.52418,977,874.92
  筹资活动现金流出小计1,937,260,773.111,072,270,504535,272,405.832,770,737,620.28
  筹资活动产生的现金流量净额45,409,226.89389,229,496283,827,594.173,461,869.72
四、汇率变动对现金及现金等价物的影响-5,527,511.73,156,614.348,909,457.0635,694,131.36
五、现金及现金等价物净增加额110,526,514.85450,706,693.16616,167,409.33-313,402,534.35
  加:期初现金及现金等价物余额936,128,317.42936,128,317.42936,128,317.421,249,530,851.77
  期末现金及现金等价物余额1,046,654,832.271,386,835,010.581,552,295,726.75936,128,317.42
补充资料:
  净利润-12,623,205.93--333,887,461.91
  资产减值准备-22,703,538.03-429,710,749.24
  固定资产和投资性房地产折旧-159,167,374.6-318,193,365.7
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-159,167,374.6-318,193,365.7
  无形资产摊销-10,004,511.65-20,040,380.72
  长期待摊费用摊销-782,127.92-1,564,255.88
  处置固定资产、无形资产和其他长期资产的损失-26,079.94--1,037,057.82
  固定资产报废损失-175,353.96--93,706.78
  公允价值变动损失--6,903,972.57-16,490,493.01
  财务费用-12,732,441.04--6,230,914.04
  投资损失-3,170,767.32--8,783,878.95
  递延所得税-3,490,759.57--8,759,100.22
  其中:递延所得税资产减少-1,176,532.31--982,938.98
    递延所得税负债增加-2,314,227.26--7,776,161.24
  存货的减少--111,184,165.2--264,233,562.75
  经营性应收项目的减少-25,443,647.95--340,299,947.31
  经营性应付项目的增加--133,458,296.19-347,634,293.1
  现金的期末余额-1,386,835,010.58-936,128,317.42
  减:现金的期初余额-936,128,317.42-1,249,530,851.77
  现金及现金等价物的净增加额-450,706,693.16--313,402,534.35
公告日期2025-10-292025-08-302025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑